Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, PhD, Arend von Stackelberg, Cornelia Eckert, PhD, Meisel Roland, MD, Pötschger Ulrike, MD, Daniel Stachel, MD, Martin Schrappe, MD, Andre Schrauder, MD, Ansgar Schulz, MD, Peter Lang, MD, Ingo Mueller, MD, Michael H. Albert, MD, Thomas Klingebiel, MD, Christina Peters, MD

Blood (2013) 122 (21): 1995.

https://doi.org/10.1182/blood.V122.21.1995.1995

Published: 2013

Journal Articles

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Matthias Pfeiffer, Ingo Mueller, Andre Schrauder, MD, Rupert Handgretinger, Peter Lang, MD

Blood (2013) 122 (21): 4573.

https://doi.org/10.1182/blood.V122.21.4573.4573

Published: 2013

Journal Articles

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, Jörg Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt

Blood (2013) 122 (1): 37–43.

https://doi.org/10.1182/blood-2013-02-484097

Published: 2013

Includes: Supplemental data

Journal Articles

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Christine von Neuhoff, Annette Sander, André Schrauder, Andrea Teigler-Schlegel, Jan Starý, Selim Corbacioglu, Dirk Reinhardt

Blood (2011) 118 (20): 5409–5415.

https://doi.org/10.1182/blood-2011-07-364661

Published: 2011

Includes: Supplemental data

Journal Articles

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Blood (2011) 118 (8): 2077–2084.

https://doi.org/10.1182/blood-2011-03-338707

Published: 2011

Includes: Supplemental data

Journal Articles

Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment

Maike Schmitz, Petra Breithaupt, Nastassja Scheidegger, Gunnar Cario, Laura Bonapace, Barbara Meissner, Paulina Mirkowska, Joelle Tchinda, Felix K. Niggli, Martin Stanulla, Martin Schrappe, Andre Schrauder, Beat C. Bornhauser, Jean-Pierre Bourquin

Blood (2011) 118 (7): 1854–1864.

https://doi.org/10.1182/blood-2010-11-320309

Published: 2011

Includes: Supplemental data

Journal Articles

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation

Blood (2011) 118 (4): 1181–1184.

https://doi.org/10.1182/blood-2011-05-356451

Published: 2011

Journal Articles

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

Gunnar Cario, Martin Zimmermann, Renja Romey, Stefan Gesk, Inga Vater, Jochen Harbott, André Schrauder, Anja Moericke, Shai Izraeli, Takashi Akasaka, Martin J. S. Dyer, Reiner Siebert, Martin Schrappe, Martin Stanulla

Blood (2010) 115 (26): 5393–5397.

https://doi.org/10.1182/blood-2009-11-256131

Published: 2010

Includes: Supplemental data

Journal Articles

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Blood (2010) 115 (16): 3206–3214.

https://doi.org/10.1182/blood-2009-10-248146

Published: 2010

Includes: Supplemental data

Journal Articles

Very Early/Early Relapses of ALL Show Unexpected Changes of Clonal Markers and High Heterogeneity in Initial and Relapse Treatment Response: ALL-BFM 2000 and ALL-REZ BFM 96/2002 .

Cornelia Eckert, Rolf Koehler, Thomas Flohr, Nikola Hagedorn, Anja Moericke, Martin Stanulla, Renate Kirschner-Schwabe, Gunnar Cario, Arend von Stackelberg, Claus R Bartram, Guenter Henze, Martin Schrappe, Andre Schrauder

Blood (2009) 114 (22): 2612.

https://doi.org/10.1182/blood.V114.22.2612.2612

Published: 2009

Journal Articles

Thiopurine Methyltransferase Genetics Is Associated with Treatment Outcome and Hepatic Toxicity in Pediatric Patients with Acute Lymphoblastic Leukemia: a Report From the ALL-BFM Study Group.

Martin Stanulla, MD, Elke Schäffeler, PhD, Silke Pohlschmidt, Martin Zimmermann, PhD, Anja Möricke, MD, Gunnar Cario, MD, Andre Schrauder, MD, Karl Welte, MD, Jochen Harbott, PhD, Wolf-Dieter Ludwig, MD, Alfred Reiter, MD, Michel Eichelbaum, MD, Martin Schrappe, MD, Matthias Schwab, MD

Blood (2009) 114 (22): 2625.

https://doi.org/10.1182/blood.V114.22.2625.2625

Published: 2009

Journal Articles

Leukemia-Initiating Cells Are Frequent in Very High Risk Childhood Acute Lymphoblastic Leukemia and Give Rise to Relatively Stable Phenotypes in Immunodeficient Mice.

Maike Schmitz, MSc, Paulina Mirkowska, MSc, Petra Breithaupt, PhD, Barbara Meissner, MD, Gunnar Cario, MD, Andre Schrauder, MD, Felix Niggli, MD, Martin Schrappe, MD, Martin Stanulla, MD, Beat Bornhauser, PhD, Jean-Pierre Bourquin, MD, PhD

Blood (2009) 114 (22): 86.

https://doi.org/10.1182/blood.V114.22.86.86

Published: 2009

Journal Articles

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols

Martin Stanulla, Elke Schaeffeler, Anja Möricke, Sally A. Coulthard, Gunnar Cario, André Schrauder, Peter Kaatsch, Michael Dördelmann, Karl Welte, Martin Zimmermann, Alfred Reiter, Michel Eichelbaum, Hansjörg Riehm, Martin Schrappe, Matthias Schwab

Blood (2009) 114 (7): 1314–1318.

https://doi.org/10.1182/blood-2008-12-193250

Published: 2009

Journal Articles

No Influence on the Incidence of Osteonecroses When Dexamethasone Replaces Prednisone during Induction Treatment for Childhood ALL: Results of Trial ALL-BFM 2000.

Anja Möricke, MD, Martin Zimmermann, PhD, Andre Schrauder, MD, Martin Stanulla, MD, Hansjörg Schmid, MD, Rüdiger Fengler, MD, Michael Frühwald, MD, Georg Mann, MD, Martin Schrappe, MD

Blood (2008) 112 (11): 899.

https://doi.org/10.1182/blood.V112.11.899.899

Published: 2008

Journal Articles

Time Point-Dependent Concordance of Flow Cytometry and RQ-PCR in the MRD Detection in Childhood ALL: The Experience of the AIEOP-BFM- ALL MRD Study Group

Giuseppe Gaipa, MD, Giovanni Cazzaniga, Renate E Panzer-Grümayer, Marinella Veltroni, Leonid Karawajew, Daniela Silvestri, Barbara Buldini, Richard Ratei, Andre Schrauder, Martin Schrappe, Wolf-Dieter Ludwig, Maria Grazia Valsecchi, Andrea Biondi, Michael N Dworzak, Giuseppe Basso

Blood (2008) 112 (11): 700.

https://doi.org/10.1182/blood.V112.11.700.700

Published: 2008

Journal Articles

Early Diagnosis and Molecular-Based Treatment of Very Highly Resistant Acute Lymphoblastic Leukemia in Childhood

Gunnar Cario, MD, Andre Schrauder, MD, Anja Moericke, MD, Jean-Pierre Bourquin, MD, Martin Schrappe, MD, Martin Stanulla, MD

Blood (2008) 112 (11): 754.

https://doi.org/10.1182/blood.V112.11.754.754

Published: 2008

Journal Articles

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert

Blood (2007) 110 (12): 4022–4029.

https://doi.org/10.1182/blood-2007-04-082040

Published: 2007

Includes: Supplemental data

Journal Articles

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Tomasz Szczepanski, MD, PhD, Vincent H.J. van der Velden, PhD, Pieter Van Vlierberghe, Bernd Gruhn, MD, PhD, Renate Panzer-Grumayer, MD, PhD, Monica Spinelli, Helene Cave, PhD, Udo zur Stadt, PhD, Dario Campana, MD, PhD, Andre Schrauder, MD, PhD, Elisabeth van Wering, PhD, Jules P.P. Meijerink, PhD, Jacques J.M. van Dongen, MD, PhD

Blood (2007) 110 (11): 1435.

https://doi.org/10.1182/blood.V110.11.1435.1435

Published: 2007

Journal Articles

CD34+CD19−, CD34+CD19+ and CD34−CD19+ Cells May All Have Leukemia-Initiating Potential in NOD/ Scid Mice.

Christoph Le Viseur, Marc Hotfilder, PhD, Annegret Rosemann, Ronald Stam, PhD, Andre Schrauder, MD, Leonard Shultz, PhD, Martin Schrappe, MD, Rob Pieters, MD, Josef Vormoor, MD

Blood (2006) 108 (11): 2542.

https://doi.org/10.1182/blood.V108.11.2542.2542

Published: 2006

Journal Articles

High Interleukin 15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia with Involvement of the Central Nervous System.

Gunnar Cario, MD, Anja Teichert, Peter Rhein, Andre Schrauder, MD, Julia Skokowa, MD PhD, Wolf-Dieter Ludwig, MD PhD, Shai Izraeli, MD, Karl Welte, MD PhD, Brigitte Schlegelberger, MD PhD, Martin Schrappe, MD PhD, Martin Stanulla, MD MSc

Blood (2006) 108 (11): 2270.

https://doi.org/10.1182/blood.V108.11.2270.2270

Published: 2006

NARROW

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Very Early/Early Relapses of ALL Show Unexpected Changes of Clonal Markers and High Heterogeneity in Initial and Relapse Treatment Response: ALL-BFM 2000 and ALL-REZ BFM 96/2002 .

Thiopurine Methyltransferase Genetics Is Associated with Treatment Outcome and Hepatic Toxicity in Pediatric Patients with Acute Lymphoblastic Leukemia: a Report From the ALL-BFM Study Group.

Leukemia-Initiating Cells Are Frequent in Very High Risk Childhood Acute Lymphoblastic Leukemia and Give Rise to Relatively Stable Phenotypes in Immunodeficient Mice.

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols

No Influence on the Incidence of Osteonecroses When Dexamethasone Replaces Prednisone during Induction Treatment for Childhood ALL: Results of Trial ALL-BFM 2000.

Time Point-Dependent Concordance of Flow Cytometry and RQ-PCR in the MRD Detection in Childhood ALL: The Experience of the AIEOP-BFM- ALL MRD Study Group

Early Diagnosis and Molecular-Based Treatment of Very Highly Resistant Acute Lymphoblastic Leukemia in Childhood

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

CD34+CD19−, CD34+CD19+ and CD34−CD19+ Cells May All Have Leukemia-Initiating Potential in NOD/ Scid Mice.

High Interleukin 15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia with Involvement of the Central Nervous System.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only